141 related articles for article (PubMed ID: 37443517)
1. The relationship between papillary thyroid carcinoma and preoperative TSH level: A cross-sectional study from Syria.
Shahrokh M; Alsultan M; Kabalan Y
Medicine (Baltimore); 2023 Jul; 102(28):e34283. PubMed ID: 37443517
[TBL] [Abstract][Full Text] [Related]
2. Association between preoperative thyrotrophin and clinicopathological and aggressive features of papillary thyroid cancer.
Tam AA; Ozdemir D; Aydın C; Bestepe N; Ulusoy S; Sungu N; Ersoy R; Cakir B
Endocrine; 2018 Mar; 59(3):565-572. PubMed ID: 29374347
[TBL] [Abstract][Full Text] [Related]
3. Association between preoperative serum TSH and tumor status in patients with papillary thyroid microcarcinoma.
Mao A; An N; Wang J; Wu Y; Wang T; Wang Z; Guan H; Wang J
Endocrine; 2021 Sep; 73(3):617-624. PubMed ID: 33755880
[TBL] [Abstract][Full Text] [Related]
4. Thyrotropin serum concentrations in patients with papillary thyroid microcancers.
Gerschpacher M; Göbl C; Anderwald C; Gessl A; Krebs M
Thyroid; 2010 Apr; 20(4):389-92. PubMed ID: 20210672
[TBL] [Abstract][Full Text] [Related]
5. [Clinical analysis of lymphocytic thyroiditis coexistent with papillary thyroid carcinoma].
Wang SX; She ZQ; An CM; Zhang XW; Li ZJ; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 51(4):277-81. PubMed ID: 27095720
[TBL] [Abstract][Full Text] [Related]
6. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role.
Fiore E; Rago T; Provenzale MA; Scutari M; Ugolini C; Basolo F; Di Coscio G; Berti P; Grasso L; Elisei R; Pinchera A; Vitti P
Endocr Relat Cancer; 2009 Dec; 16(4):1251-60. PubMed ID: 19528244
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between serum thyroxin-stimulating hormone and papillary thyroid micrcarcinoma in nodular thyroid disease].
Jiao J; Zhou Y
Zhonghua Yi Xue Za Zhi; 2015 Mar; 95(12):908-11. PubMed ID: 26081052
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound, laboratory and histopathological insights in diagnosing papillary thyroid carcinoma in a paediatric population: a single centre follow-up study between 2000-2022.
Januś D; Wójcik M; Taczanowska-Niemczuk A; Kiszka-Wiłkojć A; Kujdowicz M; Czogała M; Górecki W; Starzyk JB
Front Endocrinol (Lausanne); 2023; 14():1170971. PubMed ID: 37274328
[TBL] [Abstract][Full Text] [Related]
9. Preoperative ultrasonography and serum thyroid-stimulating hormone on predicting central lymph node metastasis in thyroid nodules as or suspicious for papillary thyroid microcarcinoma.
Gao Y; Qu N; Zhang L; Chen JY; Ji QH
Tumour Biol; 2016 Jun; 37(6):7453-9. PubMed ID: 26678888
[TBL] [Abstract][Full Text] [Related]
10. The Inverse Association of Serum Magnesium with Papillary Thyroid Cancer in Thyroid Nodules: a Cross-Sectional Survey Based on Thyroidectomy Population.
Xu H; Hu X; Li J; Nie Z; Kang S; Liu H; Wang Y; Jia X; Lyu Z
Biol Trace Elem Res; 2023 Jul; 201(7):3279-3289. PubMed ID: 36227448
[TBL] [Abstract][Full Text] [Related]
11. Preoperative TSH level and risk of thyroid cancer in patients with nodular thyroid disease: nodule size contribution.
Zafón C; Obiols G; Mesa J
Endocrinol Nutr; 2015 Jan; 62(1):24-8. PubMed ID: 25066642
[TBL] [Abstract][Full Text] [Related]
12. Inverse Relationship of BMI to TSH and Risk of Papillary Thyroid Cancer in Surgical Patients.
Handelsman RS; Alvarez AL; Picado O; Farrá JC; Lew JI
J Surg Res; 2019 Dec; 244():96-101. PubMed ID: 31280000
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between high serum thyroid-stimulating hormone level and risk of papillary thyroid microcarcinomas.
Sohn SY; Kim HJ; Jang HW; Kim SW; Chung JH
Head Neck; 2014 Jan; 36(1):43-6. PubMed ID: 23728859
[TBL] [Abstract][Full Text] [Related]
14. Benign and malignant thyroid nodules with autoimmune thyroiditis.
Kassi GN; Evangelopoulou CC; Papapostolou KD; Karga HJ
Arch Endocrinol Metab; 2022 Sept 08; 66(4):446-451. PubMed ID: 35657125
[TBL] [Abstract][Full Text] [Related]
15. 25-Hydroxyvitamin D and TSH as Risk Factors or Prognostic Markers in Thyroid Carcinoma.
Danilovic DL; Ferraz-de-Souza B; Fabri AW; Santana NO; Kulcsar MA; Cernea CR; Marui S; Hoff AO
PLoS One; 2016; 11(10):e0164550. PubMed ID: 27737011
[TBL] [Abstract][Full Text] [Related]
16. The clinical features of papillary thyroid cancer in Hashimoto's thyroiditis patients from an area with a high prevalence of Hashimoto's disease.
Zhang L; Li H; Ji QH; Zhu YX; Wang ZY; Wang Y; Huang CP; Shen Q; Li DS; Wu Y
BMC Cancer; 2012 Dec; 12():610. PubMed ID: 23256514
[TBL] [Abstract][Full Text] [Related]
17. Preoperative thyrotropin serum concentrations gradually increase from benign thyroid nodules to papillary thyroid microcarcinomas then to papillary thyroid cancers of larger size.
Zafon C; Obiols G; Baena JA; Castellví J; Dalama B; Mesa J
J Thyroid Res; 2012; 2012():530721. PubMed ID: 21860806
[TBL] [Abstract][Full Text] [Related]
18. Risk factors stratifying malignancy of nodules in contralateral thyroid lobe in patients with pre-operative ultrasound indicated unilateral papillary thyroid carcinoma: A retrospective analysis from single centre.
Lv T; Zhu C; Di Z
Clin Endocrinol (Oxf); 2018 Feb; 88(2):279-284. PubMed ID: 29083503
[TBL] [Abstract][Full Text] [Related]
19. Is thyroid hormone supplementation avoidable for patients with low-risk papillary thyroid cancer after thyroid lobectomy? A two-center observational study.
Xiao L; Wu J; Jiang L; Xu Y; Liu B
Clin Endocrinol (Oxf); 2022 Mar; 96(3):413-418. PubMed ID: 34398464
[TBL] [Abstract][Full Text] [Related]
20. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
